Vir Biotechnology, Inc. (VIR) · Insider trading
What Vir Biotechnology's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$13.00M
8 insiders, 100% under a plan
Net, 12 months
−$13.00M
bought less sold
Latest filing
2026-08-12
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Sb Investment Advisers (uk) Ltd10% owner | – | $17.85M | 21 | 2025-12-01 | – |
| Sato Vicki LDirector | – | $2.20M | 15 | 2026-05-01 | 1,078,391 |
| De Backer MarianneDirector, President and CEO | – | $1.57M | 5 | 2026-04-06 | 948,145 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | – | $411,028 | 11 | 2026-02-25 | 112,982 |
| Scangos George ADirector | – | $202,586 | 2 | 2025-02-24 | 698,239 |
| Sabatini BrentSVP, Chief Accounting Officer | – | $142,132 | 7 | 2026-06-01 | 61,902 |
| Hanly Ann M.EVP & Chief Technology Officer | – | $133,888 | 1 | 2025-02-24 | 117,901 |
| Eisner MarkEVP and Chief Medical Officer | – | $106,303 | 5 | 2026-02-25 | 154,024 |
| O'Byrne JasonEVP & Chief Financial Officer | – | $68,938 | 3 | 2026-02-24 | 162,615 |
| Napolitano JanetDirector | – | $46,400 | 2 | 2026-06-01 | 21,216 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 379 | 9.45 | $3,582 | 61,902 | Form 4 |
| 2026-06-01 | Napolitano JanetDirector | Saleplan | 3,200 | 9.45 | $30,240 | 21,216 | Form 4 |
| 2026-05-01 | Sato Vicki LDirector | Saleplan | 22,000 | 10.05 | $221,100 | 1,078,391 | Form 4 |
| 2026-04-06 | De Backer MarianneDirector, President and CEO | Saleplan | 72,559 | 9.16 | $664,640 | 948,145 | Form 4 |
| 2026-04-01 | Sato Vicki LDirector | Saleplan | 22,000 | 9.07 | $199,540 | 1,100,391 | Form 4 |
| 2026-03-23 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 7,711 | 9.12 | $70,324 | 61,902 | Form 4 |
| 2026-03-02 | Sato Vicki LDirector | Saleplan | 21,800 | 9.50 | $207,100 | 1,122,591 | Form 4 |
| 2026-03-02 | Sato Vicki LDirector | Saleplan | 200 | 9.98 | $1,996 | 1,122,391 | Form 4 |
| 2026-02-25 | de Verneuil VaninaEVP, General Counsel, Corp Sec | Saleplan | 13,700 | 9.82 | $134,534 | 112,982 | Form 4 |
| 2026-02-25 | Eisner MarkEVP and Chief Medical Officer | Saleplan | 1,889 | 9.82 | $18,550 | 154,024 | Form 4 |
| 2026-02-24 | De Backer MarianneDirector, Chief Executive Officer | Saleplan | 14,762 | 9.53 | $140,682 | 1,020,704 | Form 4 |
| 2026-02-24 | de Verneuil VaninaEVP, General Counsel, Corp Sec | Saleplan | 3,117 | 9.53 | $29,705 | 126,682 | Form 4 |
| 2026-02-24 | Eisner MarkEVP and Chief Medical Officer | Saleplan | 1,616 | 9.53 | $15,400 | 155,913 | Form 4 |
| 2026-02-24 | O'Byrne JasonEVP & Chief Financial Officer | Saleplan | 1,634 | 9.53 | $15,572 | 162,615 | Form 4 |
| 2026-02-24 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 1,430 | 9.53 | $13,628 | 69,613 | Form 4 |
| 2026-02-24 | Sato Vicki LDirector | Saleplan | 42,177 | 9.75 | $411,226 | 1,144,591 | Form 4 |
| 2026-02-24 | Sato Vicki LDirector | Saleplan | 200 | 10.26 | $2,052 | 1,144,391 | Form 4 |
| 2026-02-23 | De Backer MarianneDirector, Chief Executive Officer | Saleplan | 19,039 | 7.45 | $141,841 | 1,035,466 | Form 4 |
| 2026-02-23 | de Verneuil VaninaEVP, General Counsel, Corp Sec | Saleplan | 4,445 | 7.45 | $33,115 | 129,799 | Form 4 |
| 2026-02-23 | Eisner MarkEVP and Chief Medical Officer | Saleplan | 2,089 | 7.45 | $15,563 | 157,529 | Form 4 |
| 2026-02-23 | O'Byrne JasonEVP & Chief Financial Officer | Saleplan | 2,089 | 7.45 | $15,563 | 164,249 | Form 4 |
| 2026-02-23 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 1,829 | 7.45 | $13,626 | 71,043 | Form 4 |
| 2026-02-13 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 1,530 | 7.79 | $11,919 | 47,872 | Form 4 |
| 2026-02-02 | Sato Vicki LDirector | Saleplan | 22,000 | 7.71 | $169,620 | 1,144,391 | Form 4 |
| 2026-01-02 | Sato Vicki LDirector | Saleplan | 22,000 | 5.93 | $130,460 | 1,166,391 | Form 4 |
| 2025-12-01 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 191,854 | 5.98 | $1.15M | 13,728,924 | Form 4 |
| 2025-12-01 | Sato Vicki LDirector | Saleplan | 22,000 | 6.00 | $132,000 | 1,188,391 | Form 4 |
| 2025-11-28 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 61,493 | 6.44 | $396,015 | 13,920,778 | Form 4 |
| 2025-11-26 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 127,938 | 6.39 | $817,524 | 13,982,271 | Form 4 |
| 2025-11-25 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 235,971 | 6.38 | $1.51M | 14,110,209 | Form 4 |
| 2025-11-24 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 227,803 | 6.15 | $1.40M | 14,346,180 | Form 4 |
| 2025-11-17 | O'Byrne JasonEVP & Chief Financial Officer | Saleplan | 6,799 | 5.56 | $37,802 | 110,701 | Form 4 |
| 2025-11-05 | de Verneuil VaninaEVP, General Counsel, Corp Sec | Saleplan | 2,385 | 5.16 | $12,307 | 78,210 | Form 4 |
| 2025-11-03 | Sato Vicki LDirector | Saleplan | 22,000 | 5.64 | $124,080 | 1,210,391 | Form 4 |
| 2025-11-03 | de Verneuil VaninaEVP and General Counsel | Saleplan | 1,365 | 5.86 | $7,999 | 80,595 | Form 4 |
| 2025-10-29 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 100 | 6.49 | $649 | 14,573,983 | Form 4 |
| 2025-10-28 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 24,453 | 6.50 | $158,944 | 14,574,083 | Form 4 |
| 2025-10-27 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 66,403 | 6.05 | $401,738 | 14,598,536 | Form 4 |
| 2025-10-24 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 46,696 | 5.96 | $278,308 | 14,664,939 | Form 4 |
| 2025-10-23 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 154,383 | 5.99 | $924,754 | 14,711,635 | Form 4 |
32 more
| 2025-10-22 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 144,266 | 6.15 | $887,236 | 14,866,018 | Form 4 |
| 2025-10-21 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 109,675 | 6.30 | $690,952 | 15,010,284 | Form 4 |
| 2025-10-20 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 220,535 | 6.20 | $1.37M | 15,119,959 | Form 4 |
| 2025-10-16 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 12,844 | 6.10 | $78,348 | 15,340,494 | Form 4 |
| 2025-10-15 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 16,671 | 6.07 | $101,193 | 15,353,338 | Form 4 |
| 2025-10-10 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 2,300 | 6.08 | $13,984 | 15,370,009 | Form 4 |
| 2025-10-09 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 249,060 | 6.14 | $1.53M | 15,372,309 | Form 4 |
| 2025-10-08 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 466,242 | 6.05 | $2.82M | 15,621,369 | Form 4 |
| 2025-10-07 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 72,133 | 5.60 | $403,945 | 16,087,611 | Form 4 |
| 2025-10-06 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 73,955 | 5.69 | $420,804 | 16,159,744 | Form 4 |
| 2025-10-03 | Sb Investment Advisers (uk) Ltd10% ownerwith Softbank Vision Fund (aiv M1) L.P., Svf Endurance (Cayman) Ltd | Saleplanindirect | 450,342 | 5.56 | $2.50M | 16,233,699 | Form 4 |
| 2025-10-01 | Sato Vicki LDirector | Saleplan | 22,000 | 5.84 | $128,480 | 1,232,391 | Form 4 |
| 2025-09-02 | Sato Vicki LDirector | Saleplan | 22,000 | 4.99 | $109,780 | 1,254,391 | Form 4 |
| 2025-08-01 | Sato Vicki LDirector | Saleplan | 22,000 | 4.99 | $109,780 | 1,276,391 | Form 4 |
| 2025-07-17 | Eisner MarkEVP and Chief Medical Officer | Saleplan | 3,586 | 5.47 | $19,615 | 104,618 | Form 4 |
| 2025-07-15 | Eisner MarkEVP and Chief Medical Officer | Saleplan | 6,796 | 5.47 | $37,174 | 108,204 | Form 4 |
| 2025-07-01 | Sato Vicki LDirector | Saleplan | 22,000 | 5.10 | $112,200 | 1,298,391 | Form 4 |
| 2025-06-02 | Napolitano JanetDirector | Saleplan | 3,200 | 5.05 | $16,160 | 16,416 | Form 4 |
| 2025-04-03 | De Backer MarianneDirector, Chief Executive Officer | Saleplan | 79,712 | 5.95 | $474,286 | 769,505 | Form 4 |
| 2025-02-26 | de Verneuil VaninaEVP and General Counsel | Saleplan | 7,373 | 9.14 | $67,389 | 79,460 | Form 4 |
| 2025-02-24 | de Verneuil VaninaEVP and General Counsel | Saleplan | 5,140 | 9.45 | $48,573 | 86,833 | Form 4 |
| 2025-02-24 | De Backer MarianneDirector, Chief Executive Officer | Saleplan | 16,122 | 9.45 | $152,353 | 849,217 | Form 4 |
| 2025-02-24 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 1,562 | 9.45 | $14,761 | 46,627 | Form 4 |
| 2025-02-24 | Hanly Ann M.EVP & Chief Technology Officer | Saleplan | 14,168 | 9.45 | $133,888 | 117,901 | Form 4 |
| 2025-02-24 | Scangos George ADirector | Saleplan | 10,056 | 9.45 | $95,029 | 698,239 | Form 4 |
| 2025-02-18 | Scangos George ADirector | Saleplan | 10,964 | 9.81 | $107,557 | 708,295 | Form 4 |
| 2025-02-13 | Sabatini BrentSVP, Chief Accounting Officer | Saleplan | 1,562 | 9.15 | $14,292 | 28,189 | Form 4 |
| 2025-01-08 | Sato Vicki LDirector | Saleplan | 10,960 | 12.52 | $137,219 | 1,312,391 | Form 4 |
| 2024-12-02 | de Verneuil VaninaEVP and General Counsel | Sale | 76 | 8.22 | $625 | 56,973 | Form 4 |
| 2024-11-06 | de Verneuil VaninaEVP and General Counsel | Saleplan | 4,397 | 10.11 | $44,454 | 56,973 | Form 4 |
| 2024-11-05 | de Verneuil VaninaEVP and General Counsel | Saleplan | 2,347 | 9.47 | $22,226 | 61,370 | Form 4 |
| 2024-11-01 | de Verneuil VaninaEVP and General Counsel | Saleplan | 1,403 | 7.20 | $10,102 | 63,717 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
27 × grant or award14 × other1 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-11 | More Robert JDirector | Other J | −8,000 | – | 40,656 | Form 4 |
| 2026-08-11 | More Robert JDirector | Other J | +8,000 | – | 517,917 | Form 4 |
| 2026-06-09 | Coughlin TimothyDirector | Grant or award A | +8,000 | – | 8,000 | Form 4 |
| 2026-06-09 | Coughlin TimothyDirector | Grant or award A | +8,000 | – | 16,000 | Form 4 |
| 2026-05-27 | Bischofberger Norbert WDirector | Grant or award A | +8,000 | – | 21,333 | Form 4 |
| 2026-05-27 | Farid RamyDirector | Grant or award A | +8,000 | – | 32,000 | Form 4 |
| 2026-05-27 | Hatfield Jeffrey S.Director | Grant or award A | +8,000 | – | 39,806 | Form 4 |
| 2026-05-27 | More Robert JDirector | Grant or award A | +8,000 | – | 48,656 | Form 4 |
| 2026-05-27 | Napolitano JanetDirector | Grant or award A | +8,000 | – | 24,416 | Form 4 |
| 2026-05-27 | Sigal Charles ElliottDirector | Grant or award A | +8,000 | – | 39,806 | Form 4 |
| 2026-04-29 | De Backer MarianneDirector, President and CEO | Other J | −233,532 | – | 714,613 | Form 4 |
| 2026-04-29 | De Backer MarianneDirector, President and CEO | Other J | +233,532 | – | 286,650 | Form 4 |
| 2026-03-20 | O'Byrne JasonEVP & Chief Financial Officer | Other J | −2,500 | – | 160,115 | Form 4 |
| 2026-03-20 | O'Byrne JasonEVP & Chief Financial Officer | Other J | +2,500 | – | 2,500 | Form 4 |
| 2026-02-24 | Sato Vicki LDirector | Option exercise M | +42,377 | 1.49 | 1,186,768 | Form 4 |
| 2026-02-22 | De Backer MarianneDirector, Chief Executive Officer | Grant or award A | +285,000 | – | 1,054,505 | Form 4 |
| 2026-02-22 | de Verneuil VaninaEVP, General Counsel, Corp Sec | Grant or award A | +55,000 | – | 134,244 | Form 4 |
| 2026-02-22 | Eisner MarkEVP and Chief Medical Officer | Grant or award A | +55,000 | – | 159,618 | Form 4 |
| 2026-02-22 | O'Byrne JasonEVP & Chief Financial Officer | Grant or award A | +55,000 | – | 166,338 | Form 4 |
| 2026-02-22 | Sabatini BrentSVP, Chief Accounting Officer | Grant or award A | +25,000 | – | 72,872 | Form 4 |
| 2025-06-09 | More Robert JDirector | Other J | −14,027 | – | 40,656 | Form 4 |
| 2025-06-09 | More Robert JDirector | Other J | +14,027 | – | 509,917 | Form 4 |
| 2025-06-06 | Bischofberger Norbert WDirector | Other J | −10,667 | – | 13,333 | Form 4 |
| 2025-06-06 | Bischofberger Norbert WDirector | Other J | +10,667 | – | 10,667 | Form 4 |
| 2025-05-30 | Bischofberger Norbert WDirector | Grant or award A | +8,000 | – | 24,000 | Form 4 |
| 2025-05-30 | Farid RamyDirector | Grant or award A | +8,000 | – | 24,000 | Form 4 |
| 2025-05-30 | Hatfield Jeffrey S.Director | Grant or award A | +8,000 | – | 31,806 | Form 4 |
| 2025-05-30 | More Robert JDirector | Grant or award A | +8,000 | – | 54,683 | Form 4 |
| 2025-05-30 | Napolitano JanetDirector | Grant or award A | +8,000 | – | 19,616 | Form 4 |
| 2025-05-30 | Ramasastry SairaDirector | Grant or award A | +8,000 | – | 22,619 | Form 4 |
| 2025-05-30 | Sato Vicki LDirector | Grant or award A | +8,000 | – | 1,320,391 | Form 4 |
| 2025-05-30 | Sigal Charles ElliottDirector | Grant or award A | +8,000 | – | 31,806 | Form 4 |
| 2025-02-22 | de Verneuil VaninaEVP and General Counsel | Grant or award A | +35,000 | – | 91,973 | Form 4 |
| 2025-02-22 | De Backer MarianneDirector, Chief Executive Officer | Grant or award A | +240,000 | – | 865,339 | Form 4 |
| 2025-02-22 | Sabatini BrentSVP, Chief Accounting Officer | Grant or award A | +20,000 | – | 48,189 | Form 4 |
| 2025-02-22 | Eisner MarkEVP and Chief Medical Officer | Grant or award A | +40,000 | – | 115,000 | Form 4 |
| 2025-02-22 | O'Byrne JasonEVP & Chief Financial Officer | Grant or award A | +40,000 | – | 115,000 | Form 4 |
| 2024-11-15 | O'Byrne JasonEVP & Chief Financial Officer | Grant or award A | +75,000 | – | 75,000 | Form 4 |
| 2024-10-23 | Scangos George ADirector | Other J | +598,270 | – | 719,259 | Form 4 |
| 2024-10-23 | Scangos George ADirector | Other J | −598,270 | – | 1,151,730 | Form 4 |
| 2024-10-23 | Scangos George ADirector | Other J | +598,270 | – | 598,270 | Form 4 |
| 2024-10-23 | Scangos George ADirector | Other J | −598,270 | – | 1,151,730 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.